Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of indomethacin oral mucosa-adaptive formulation in healthy adults
jRCTs031220121Completed
- Sponsor
- Falnex
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indomethacin in stomatitis, sponsored by Falnex. Primary endpoint: Irritation to the oral mucosa (presence of inflammation). Started Jul 2022; status: completed.
02
Drugs
indomethacin
03
Conditions
stomatitis
Beyond the preview
Go deeper on jRCTs031220121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220121.